RecruitingNCT06375122
25
studies recruiting now
as of 7 Sept 2026
191
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
28 Aug 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT03300830
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
RecruitingNCT00006518
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
RecruitingNot applicableNCT07793006
New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease
RecruitingPhase 2NCT07308886
Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 25 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Kaposi sarcoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Kaposi sarcoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
6 approved treatments and 31 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Interferon Alfa-2b (Intron a)Approved: Doxorubicin Hydrochloride (Adriamycin)Approved: Paclitaxel (Abraxane)Approved: Alitretinoin (Panretin)Approved: Doxorubicin (Adriblastina)Approved: Daunorubicin (Daunorubicin component of vyxeos)
Phase 3Rebimastat
Phase 2/3Ritonavir (Norvir)
Phase 2/3Abacavir (Ziagen)
Phase 2/3Zidovudine (Retrovir)
Phase 2/3Lamivudine (Epivir)
Phase 2/3Lopinavir (Lopinavir component of kaletra)
Phase 2Sunitinib Malate (Sunitinib malate)
Phase 2Propranolol
+ 23 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).